Figure 4From: Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer Platelet count of patient 4 treated with weekly carboplatin AUC 3 and paclitaxel 20 mg/m 2 (hatched bars). Single agent carboplatin AUC 3 (solid bar). Serum CA 125 (U/ml)(solid line).Back to article page